Clinical Trials Logo

Clinical Trial Summary

This trial studies how well the diagnostic deoxyribonucleic acid (DNA) methylation signature works in detecting thyroid cancer in patients with thyroid nodules. Using diagnostic testing, such as the diagnostic DNA methylation signature, may be a less invasive way to check for thyroid cancer.


Clinical Trial Description

PRIMARY OBJECTIVES: I. To validate a novel epigenetic thyroid nodule diagnostic test, diagnostic DNA methylation signature (DDMS) in a retrospective-prospective study with leftover of fine needle aspiration biopsies. OUTLINE: Previously collected FNA aspiration specimen samples are analyzed via DDMS assay. Participants undergo FNA aspiration for collection of tissue samples for analysis via DDMS assay. After completion of study, patients are followed up yearly for 5 years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03676647
Study type Observational
Source City of Hope Medical Center
Contact
Status Withdrawn
Phase
Start date June 1, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT03174925 - Ultrasound Elastography in Imaging Patients With Thyroid Nodules N/A
Suspended NCT04742608 - Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Recruiting NCT05003856 - Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule N/A